Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;37(6):e749-e751.
doi: 10.1111/jdv.18907. Epub 2023 Jan 31.

Anti-interleukin-17A biologics for the long-term treatment of bullous pemphigoid: A prospective, cohort study

K Bakirtzi  1 , E Sotiriou  1 , I Papadimitriou  1 , E Vakirlis  1 , F S Delli  2 , D Ioannides  1
Affiliations

Anti-interleukin-17A biologics for the long-term treatment of bullous pemphigoid: A prospective, cohort study

K Bakirtzi et al. J Eur Acad Dermatol Venereol. 2023 Jun.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Chakievska L, Holtsche MM, Künstner A, Goletz S, Petersen BS, Thaci D, et al. IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid. J Autoimmun. 2019;96:104-12.
    1. Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol. 2012;66(3):479-85.
    1. Lu L, Yu Y, Zhang J, Fan X, Qi Y, Lin B. Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis. J Dermatol. 2022;49(1):e13-5.
    1. Kamata M, Asano Y, Shida R, Maeda N, Yoshizaki A, Miyagaki T, et al. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. J Dermatol. 2019;46(6):e216-7.
    1. Holtsche MM, Hammers CM, Chakievska L, Ludwig RJ, Thaci D, Zillikens D, et al. Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid. J Dtsch Dermatol Ges. 2020;18(12):1478-80.

LinkOut - more resources